Safety and preliminary clinical activity of NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1 fusion-positive solid tumors. (October 2022)
- Record Type:
- Journal Article
- Title:
- Safety and preliminary clinical activity of NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1 fusion-positive solid tumors. (October 2022)
- Main Title:
- Safety and preliminary clinical activity of NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1 fusion-positive solid tumors
- Authors:
- Drilon, A.
Besse, B.
Camidge, D.R.
Ou, S.H.I.
Gadgeel, S.M.
Johnson, M.L.
Calles, A.
de Miguel, M.J.
Spira, A.I.
Felip, E.
Lopes, G.
van der Wekken, A.J.
Elamin, Y.Y.
Green, J.
Sun, Y.
Soglia, J.
Zhu, V.W.
Lin, J.J. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 174(2022)Supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 174(2022)Supplement 1
- Issue Display:
- Volume 174, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 174
- Issue:
- 1
- Issue Sort Value:
- 2022-0174-0001-0000
- Page Start:
- S6
- Page End:
- S7
- Publication Date:
- 2022-10
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(22)00821-8 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24203.xml